VAR-101

N/A

Report date: 2024/12/11 16:59:34
NME

Base Information

Drug NameVAR-101
Drug Alias NameVAR-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitors
TargetsProtein kinase C
Therapy Area/IndicationsCarcinoma, Basal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVarian Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesVarian Biopharmaceuticals IncWindtree Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Basal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A